Navigation Links
Survey Reveals Significant Public Lack of Diabetes Awareness

MINNEAPOLIS--(BUSINESS WIRE)--Mar 27, 2007 - According to a recent nationwide survey released today, nearly 80 percent of the American public does not know the difference between type 1 and type 2 diabetes. The survey, conducted by Harris Interactive(R) and commissioned by Medtronic, Inc. (NYSE:MDT), showed that almost half of respondents were also unaware that two distinct forms of diabetes existed. The results of the survey, particularly those focusing on type 1 diabetes, corroborate Medtronic's decision to announce today the launch of an education initiative to raise awareness of type 1 diabetes, and the most effective therapy options available to treat it.

"The diabetes community has speculated for some time about the public's poor understanding of type 1 diabetes. These survey results unfortunately confirm our fears," said Francine Kaufman, MD, director of the Comprehensive Childhood Diabetes Center and head of the Center for Endocrinology, Diabetes and Metabolism at Children's Hospital Los Angeles. "Type 1 diabetes is a life-long disease that occurs most often in children, although it can manifest itself in adults. Type 1 requires daily intensive insulin therapy to maintain a normal quality of life, and has nothing to do with a patient's diet or lack of exercise."

In the survey, nearly 70 percent of people incorrectly believed a cure existed for type 1 diabetes. The majority of respondents mentioned proper diet (25%), weight loss (18%), exercise (22%), insulin (16%) or other medication (12%) - as ways patients could cure their type 1 diabetes. These misconceptions reaffirm many of the myths associated with the disease. They also draw attention away from the need for intensive and aggressive insulin management of type 1 diabetes to reduce the incidence of long-term complications. Some of the most advanced therapy options currently available for patients include insulin pump therapy and continuous gl ucose monitoring (CGM) systems.

In order to dispel the myths associated with type 1 diabetes, and raise awareness of currently available therapy options, Medtronic is funding a series of educational initiatives across the county this summer. These local events, the first taking place in Miami this May, will educate interested individuals in the epidemiology and therapy options for type 1 diabetes. Presenters will share their experiences with the newest diabetes treatments available, and how these therapies can improve health outcomes and quality of life.

These educational activities will coincide with the unveiling of a new informative Web site, www.RealDiabetesControl.com, where patients can access information about the latest treatment options to improve their diabetes control. Patients also have the opportunity to sign up for an educational seminar in their local area.

"As the nation's attention turns to type 2 diabetes for the American Diabetes Alert on March 27th, it is important for people not to forget the more than one million Americans with type 1 diabetes," said Dr. Kaufman. "There is an immediate need for greater public understanding of diabetes, and the most effective ways to help diabetes patients live longer, healthier lives."

Type 1 diabetes develops when the body's immune system destroys pancreatic beta cells, the only cells that make insulin--a necessary hormone to regulate blood glucose. Type 1 patients depend on daily delivery of insulin from an insulin pump or injections to survive. Insulin pumps are the most advanced method for precise and adjustable insulin delivery. Many patients experience improved quality of life with insulin pump therapy combined with CGM technology, which is clinically proven to help patients monitor and better control their diabetes. For more information about type 1 diabetes and its treatment options, please visit www.RealDiabetesControl.com.

Survey Key Findings

-- 78 percent of those polled did not know the difference between type 1 and type 2 diabetes

-- 67 percent of the population mistakenly believed there is a cure for type 1 diabetes

-- Only 51 percent knew that there were two types of diabetes

Survey Methodology

This survey was conducted online within the United States by Harris Interactive(R) on behalf of Medtronic between March 7 and 9, 2007, via its QuickQuery(SM) online omnibus service, among 2,436 U.S. adults aged 18 years and older. Figures for region, age within gender, education, household income, race/ethnicity were weighted where necessary to bring them into line with their actual proportions in the population. Propensity score weighting was also used to adjust for respondents' propensity to be online.

With a pure probability sample of 2,436 one could say with a ninety-five percent probability that the overall results would have a sampling error of +/- 3 percentage points. Sampling error for data based on sub-samples would be higher and would vary. However, that does not take other sources of error into account. This online survey is not based on a probability sample and therefore no theoretical sampling error can be calculated.

Diabetes Statistics

-- According to the American Diabetes Association, almost 21 million Americans (seven percent of the population) have diabetes.(1)

-- More than one million patients in the US have type 1 diabetes, often referred to as juvenile diabetes.(2)

-- Diabetes is the fifth-deadliest disease in the United States,(3) and costs the United States more than $132 billion in direct and indirect costs.(4)

-- About 28 percent of diabetes patients use insulin to control their disease.(5) That means almost six million Americans require insulin to manage their diabetes.

About the Diabetes Business at Medtronic

The diabetes business at Medtronic (www.medtronic-diabetes.com) is the world leader in diabetes management. T he company's products include insulin pump therapy, continuous glucose monitoring systems, related disposable products and diabetes management software. In March 2007, Medtronic received FDA approval for pediatric use of its CGM systems for children and teenagers ages 7-17, marking a fundamental shift in children's ability to manage their diabetes. The company also launched the Guardian(R) REAL-Time System, featuring the new MiniLink(TM) REAL-Time Transmitter - a rechargeable, waterproof transmitter approximately one-third the size of previous Medtronic transmitters.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology, alleviating pain, restoring health and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's Annual Report on Form 10-K for the year ended April 28, 2006. Actual results may differ materially from anticipated results.

(1) http://diabetes.org/diabetes-statistics/prevalence.jsp

(2) US Opportunities in Drug Delivery Technologies published by Health Research International in July 2004

(3) http://diabetes.org/diabetes-statistics/dangerous-toll.jsp

(4) http://diabetes.org/diabetes-statistics/cost-of-diabetes-in-us.jsp

(5) http://diabetes.org/diabetes-statistics/dangerous-toll.jsp

Contact

Medtronic Diabetes
Steve Sabicer, 818-576-4826
or
Investor Relations
Jeff Warren, 763-505-2696


'"/>




Related medicine technology :

1. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
2. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
3. Waismann Method Survey Reveals Dependency Risk for People Using Suboxone
4. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
5. Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
6. New Survey Finds Troubling Data on American Asthma Sufferers
7. Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate Dependency Treatment Are Mothers
8. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
9. DVT Awareness Survey Findings for Respondents in High-Risk Groups: Obese Individuals
10. DVT Awareness Survey Findings: Heart and Respiratory Patients
11. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... "Surgical Procedure Volumes: Global Analysis (United States, China, Japan, ... report to their offering. ... tool for healthcare business planners, provides surgical procedure volume ... surgery trends with an in-depth analysis of growth drivers ...
(Date:6/23/2016)... 2016 The Biotechnology industry might ... present great opportunities to investors. Stock-Callers.com assesses the recent ... (NYSE: XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ARNA ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... receive your complimentary trade alerts at: ...
(Date:6/23/2016)... 23, 2016 Leading BioSciences Inc., a ... conditions resulting from a breakdown of the mucosal ... Greg Doyle as chief executive officer. Mr. ... management team and board of directors, previously served ... He will provide continued leadership and strategic direction ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... ambulance transport experience for the millions of people who require these medical transport ... taxi industry through the use of technology. Now, SmartEMS has put forth an ...
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... Viejo, California (PRWEB) , ... June 26, 2016 , ... ... Final Cut Pro X. , "Film editors can give their videos a whole new ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains ...
(Date:6/26/2016)... ... 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to ... app. The fitness app plans to fix the two major problems leading the fitness industry ... fits all type program , They don’t eliminate all the reasons people quit ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
Breaking Medicine News(10 mins):